Dev

Potentiels thérapeutiques de la cystamine pour la maladie de Parkinson. Potential therapeutic cystamine for Parkinson’s disease. Investments > €500k Canada Parkinson’s disease & PD-related disorders 2016    

Magnetic resonance imaging biomarkers in ALS Investments > €500k Canada Motor neurone diseases 2016    

Investigating the mechanism of Amyloid-beta GxxxG-motif-targeting agents Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Studies on the plasticity of CNS cholinergic neurons Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Cellular lipids in Huntington’s disease Investments > €500k Canada Huntington’s disease 2016    

Novel approaches to modulate key targets in the pathogenesis of Huntington Disease Investments > €500k Canada Huntington’s disease 2016    

Role of translational mechanisms in the retrograde regulation of Synaptic homeostasis Investments > €500k Canada Parkinson’s disease & PD-related disorders 2016    

Towards a better understanding of the language impairment and neural basis of primary progressive aphasia: A longitudinal study Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Aberrant phospholipid and sphingolipid metabolism is a primary and targetable pathology in Alzheimer Disease Investments > €500k Canada Alzheimer’s disease & other dementias 2016    

Investigation of the bioeffects of blood-brain barrier disruption by focused ultrasound: A multifaceted imaging approach Investments > €500k Canada Alzheimer’s disease & other dementias 2016